Results 261 to 270 of about 5,181,983 (378)
Monitoring circulating tumor DNA (ctDNA) in patients with operable breast cancer can reveal disease relapse earlier than radiology in a subset of patients. The failure to detect ctDNA in some patients with recurrent disease suggests that ctDNA could serve as a supplement to other monitoring approaches.
Kristin Løge Aanestad +35 more
wiley +1 more source
The Medicalization of Menopause: Understanding the Evolution of Treatment Approaches. [PDF]
Munshi A, Garg R.
europepmc +1 more source
TREX1, a predator for treating MSI‐H tumors?
Immunotherapy benefits many patients; yet, some with MSI‐H tumors remain unresponsive despite their high immunogenicity. Xu et al. reveal that TREX1 enables immune evasion by degrading cytosolic DNA and suppressing cGAS–STING–IFN‐I signaling. TREX1 loss restores DNA sensing, increases CD8+ T and NK cell infiltration, and boosts antitumor immunity ...
Elena Benidovskaya +2 more
wiley +1 more source
Revisiting midwifery's identity: A crucial step to support access to continuity models of care. [PDF]
Giroux J.
europepmc +1 more source
Values at Work: How Sex Discrimination Law Moved from Joke to Juggernaut in 50 Years [PDF]
Yuracko, Kimberly A.
core +2 more sources
The LINC01116 long noncoding RNA is induced by hypoxia and associated with poor prognosis and high recurrence rates in two cohorts of lung adenocarcinoma patients. Here, we demonstrate that besides its expression in cancer cells, LINC01116 is markedly expressed in lymphatic endothelial cells of the tumor stroma in which it participates in hypoxia ...
Marine Gautier‐Isola +12 more
wiley +1 more source
What are the long-term outcomes of ADHD treatment? [PDF]
Haavik J.
europepmc +1 more source
Health and Housing: Altruistic Medicalization of America’s Affordability Crisis [PDF]
Matthew, Dayna Bowen
core +1 more source

